Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.045
AS - Asia 10.699
EU - Europa 8.959
SA - Sud America 1.341
AF - Africa 251
OC - Oceania 184
Continente sconosciuto - Info sul continente non disponibili 17
Totale 37.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.531
SG - Singapore 3.123
IT - Italia 2.535
VN - Vietnam 2.282
CN - Cina 2.270
DE - Germania 1.342
HK - Hong Kong 1.135
RU - Federazione Russa 1.096
BR - Brasile 990
SE - Svezia 816
IE - Irlanda 588
GB - Regno Unito 534
IN - India 460
FR - Francia 388
UA - Ucraina 375
CA - Canada 372
FI - Finlandia 265
ID - Indonesia 190
KR - Corea 184
AU - Australia 178
PL - Polonia 171
BD - Bangladesh 156
AT - Austria 150
ES - Italia 132
TR - Turchia 126
AR - Argentina 121
DK - Danimarca 120
NL - Olanda 119
JP - Giappone 112
IQ - Iraq 107
ZA - Sudafrica 101
MX - Messico 87
PK - Pakistan 77
BE - Belgio 60
IR - Iran 56
SA - Arabia Saudita 49
CH - Svizzera 48
PH - Filippine 48
TW - Taiwan 48
UZ - Uzbekistan 48
CO - Colombia 45
VE - Venezuela 44
PT - Portogallo 39
EC - Ecuador 38
CL - Cile 34
MY - Malesia 34
RO - Romania 32
BG - Bulgaria 26
KE - Kenya 25
LT - Lituania 25
CZ - Repubblica Ceca 24
MA - Marocco 24
EG - Egitto 23
GR - Grecia 23
IL - Israele 23
PY - Paraguay 23
JO - Giordania 22
NP - Nepal 20
ET - Etiopia 17
PE - Perù 17
TN - Tunisia 17
OM - Oman 16
UY - Uruguay 16
TH - Thailandia 15
AE - Emirati Arabi Uniti 14
EU - Europa 14
AZ - Azerbaigian 12
JM - Giamaica 12
DZ - Algeria 11
HU - Ungheria 10
KZ - Kazakistan 10
BO - Bolivia 9
PA - Panama 9
AL - Albania 8
CR - Costa Rica 8
CY - Cipro 7
HN - Honduras 7
BB - Barbados 6
PS - Palestinian Territory 6
BH - Bahrain 5
LB - Libano 5
LY - Libia 5
MU - Mauritius 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
AM - Armenia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MD - Moldavia 4
NG - Nigeria 4
NO - Norvegia 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BW - Botswana 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
Totale 37.442
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Singapore 1.912
Ashburn 1.621
Hong Kong 1.088
San Jose 1.045
Milan 1.002
Woodbridge 866
Frankfurt am Main 738
Ho Chi Minh City 692
Fairfield 670
Chandler 632
Houston 582
Dublin 568
Wilmington 567
Hanoi 530
Dearborn 370
Beijing 364
Jacksonville 358
New York 345
Santa Clara 344
Dallas 341
Los Angeles 339
Seattle 330
Cambridge 246
Chicago 232
Hefei 194
Princeton 191
The Dalles 179
Nanjing 167
Melbourne 151
Council Bluffs 150
Jakarta 150
Helsinki 133
Shanghai 131
Seoul 123
Vienna 123
Lauterbourg 119
São Paulo 111
Buffalo 108
Toronto 98
Orem 96
Moscow 91
Guangzhou 87
Warsaw 75
Da Nang 74
Kraków 74
Lawrence 72
Munich 72
Tokyo 72
Haiphong 68
Chennai 65
San Diego 63
Altamura 62
Dong Ket 62
Rome 62
Ottawa 61
London 59
Lachine 58
Montreal 55
Nanchang 55
Denver 54
Fremont 53
Brussels 52
Johannesburg 51
Monza 49
Melzo 46
Nuremberg 44
Atlanta 43
Hangzhou 43
Phoenix 43
Wayne 43
Baghdad 41
Changsha 41
Pune 41
Kunming 40
Boardman 39
Ha Long 39
Boston 38
Bắc Ninh 38
Mumbai 38
Hải Dương 37
Poplar 37
Tashkent 37
Amsterdam 36
Stockholm 36
Andover 34
Brooklyn 34
Biên Hòa 33
Shenyang 33
New Delhi 32
Zurich 32
Dhaka 31
Turku 31
Zhengzhou 31
Can Tho 30
Hebei 30
Thái Nguyên 30
Paris 29
Tianjin 28
Bologna 27
Totale 23.605
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 711
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 640
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 598
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 585
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 561
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 535
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 529
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 523
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases 517
A new approach for glyco-functionalization of collagen-based biomaterials 513
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 508
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 503
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 474
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 471
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 466
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 462
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 455
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells 453
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 440
Phage-displayed peptides targeting specific tissues and organs 426
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 421
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 420
Nanomedicine for the treatment of Alzheimer's disease 415
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 412
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 408
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor 404
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 398
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 397
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 389
Are the nanoparticles friends or foes when inhaled? 389
Enhanced brain targeting of engineered solid lipid nanoparticles 388
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 383
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 372
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 368
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 351
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 344
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 344
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 343
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 338
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 332
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 331
TrkA pathway activation induced by amyloid-beta (Abeta) 329
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 329
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 327
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 321
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 318
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 316
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 316
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 310
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 309
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 302
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 302
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 302
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 301
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine 299
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 299
Effect of modified collagen on amyloid beta peptide aggregation 297
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 296
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 295
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 294
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 292
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 290
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 278
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 274
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 274
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 271
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 270
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 269
Enhanced brain targeting of engineered solid lipid nanoparticles 269
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 263
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 256
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 253
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 253
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 252
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 251
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 248
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 245
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 241
Nanotechnology for neurodegenerative disorders 240
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 240
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 237
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 236
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 236
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 236
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 235
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 234
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 231
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy 229
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 227
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 227
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 225
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 225
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 224
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 222
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 217
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 216
Nanotechnology for neurodegenerative disorders 209
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 208
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 205
Design and validation of a microfluidic device for blood-brain barrier monitoring and transport studies 205
Totale 33.892
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021537 0 0 0 0 0 0 0 0 0 0 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20255.643 280 461 393 305 456 370 387 224 618 855 530 764
2025/202614.806 2.445 987 1.230 1.650 1.851 744 2.207 862 1.276 1.443 111 0
Totale 38.445